Pathway to A Cure

Join our effort to detect myeloma sooner, customize treatment, conduct worldwide data analysis and clinical trials, and unlock the Pathway to A Cure.

Join the Conversation

Multiple myeloma is the second most common blood cancer. Yet the majority of patients have never heard of it until they are told they have the disease.

Make A Difference

Your donation today can make the difference for multiple myeloma patients in your community and around the world.

Black Swan Research Initiative Updates

  • Whats the latest update on the Black Swan Research Initiative®?

    In this week's video, Dr. Brian Durie gives an update on the exciting developments happening on

  • Freelite® and Hevylite® will help the Black Swan Research Initiative find the best treatment to cure multiple myeloma

    Binding Site, a Birmingham, UK, based In-Vitro clinical diagnostic company, is pleased to announce

  • The IMF and the Euroflow Consortium Introduce Breakthrough in Detection of Minimal Residual Disease (MRD)

    North Hollywood, CA, March 18, 2014 – The International Myeloma Foundation (IMF), in

  • Latest Myeloma Research, Live IMF Webcasts from American Society of Hematology Meeting

    North Hollywood, CA, and New Orleans, LA – December 5, 2013 – The International Myeloma

  • Onyx Pharmaceuticals partners with IMF to support Black Swan Research Initiative®

    North Hollywood, CA and South San Francisco, CA, December 6, 2013 -- The International Myeloma